Pulse Biosciences, Inc.
PLSE · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Revenue | $0 | $0 | $1 | $1 |
| % Growth | – | -100% | -50.6% | – |
| Cost of Goods Sold | $0 | $1 | $12 | $2 |
| Gross Profit | $0 | -$1 | -$11 | -$1 |
| % Margin | – | – | -1,606.3% | -38.8% |
| R&D Expenses | $32 | $28 | $21 | $29 |
| G&A Expenses | $24 | $16 | $14 | $19 |
| SG&A Expenses | $24 | $16 | $26 | $34 |
| Sales & Mktg Exp. | $0 | $0 | $12 | $15 |
| Other Operating Expenses | $0 | -$1 | $0 | $0 |
| Operating Expenses | $56 | $42 | $47 | $62 |
| Operating Income | -$56 | -$44 | -$58 | -$63 |
| % Margin | – | – | -8,293.9% | -4,443.9% |
| Other Income/Exp. Net | $3 | $1 | -$0 | -$1 |
| Pre-Tax Income | -$54 | -$42 | -$59 | -$64 |
| Tax Expense | $0 | $0 | $0 | $0 |
| Net Income | -$54 | -$42 | -$59 | -$64 |
| % Margin | – | – | -8,357.9% | -4,489.4% |
| EPS | -0.92 | -0.88 | -1.72 | -2.28 |
| % Growth | -4.5% | 48.8% | 24.6% | – |
| EPS Diluted | -0.92 | -0.88 | -1.72 | -2.28 |
| Weighted Avg Shares Out | 58 | 48 | 34 | 28 |
| Weighted Avg Shares Out Dil | 58 | 48 | 34 | 28 |
| Supplemental Information | – | – | – | – |
| Interest Income | $3 | $2 | $0 | $0 |
| Interest Expense | $0 | $1 | $0 | $0 |
| Depreciation & Amortization | $1 | $1 | $1 | $1 |
| EBITDA | -$55 | -$42 | -$57 | -$62 |
| % Margin | – | – | -8,100.3% | -4,363% |